FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ulrich Kalinke

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Disorders

Rhabdoviridae Infections

Procedures

Co-author Network

Publications

TOP 3
Francesca Prete; Mirjam van der Burg; william vermi; Anna Villa; Alessandro Aiuti; Elisa Bonomi; Robbert Bredius; Caterina Cancrini; Maria Carmina Castiello; Marco Catucci; Stefania Gobessi; Sophie Hambleton; Ulrich Kalinke; Mayrel Labrada; Ayse Metin; Luigi Daniele Notarangelo; Federica Benvenuti
Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
Katrin Högner; Ulrich Kalinke; Peter Lewe-Schlosser; Juergen Lohmeyer; Mikhail Matrosovich; Stephan Pleschka; Stephanie Plog; Werner Seeger; Hans-Dieter Walmrath; Thorsten Wolff; Johannes Bodner; Stefan Gattenlöhner; Achim D Gruber; Susanne Herold
Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia.
Sabrina Weissmüller; Stefan Christians; Ulrich Kalinke; Jan Muller-Berghaus; Linda Y Semmler; Zoe Waibler
ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ulrich Kalinke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Francesca Prete; Mirjam van der Burg; william vermi; Anna Villa; Alessandro Aiuti; Elisa Bonomi; Robbert Bredius; Caterina Cancrini; Maria Carmina Castiello; Marco Catucci; Stefania Gobessi; Sophie Hambleton; Ulrich Kalinke; Mayrel Labrada; Ayse Metin; Luigi Daniele Notarangelo; Federica Benvenuti
Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
The Journal of experimental medicine 2013;210(2):355-74.
2013: Katrin Högner; Ulrich Kalinke; Peter Lewe-Schlosser; Juergen Lohmeyer; Mikhail Matrosovich; Stephan Pleschka; Stephanie Plog; Werner Seeger; Hans-Dieter Walmrath; Thorsten Wolff; Johannes Bodner; Stefan Gattenlöhner; Achim D Gruber; Susanne Herold
Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia.
PLoS pathogens 2013;9(2):e1003188.
2012: Sabrina Weissmüller; Stefan Christians; Ulrich Kalinke; Jan Muller-Berghaus; Linda Y Semmler; Zoe Waibler
ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation.
Blood 2012;119(26):6268-77.
2012: Elisabeth Kernbauer; Verena Maier; Mathias Müller; U Reichart; Boris Reizis; Christine Schneckenleithner; Veronika Sexl; Dagmar Stoiber; Birgit Strobl; Amanda Jamieson; Ulrich Kalinke; Thomas Decker
Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection.
PLoS pathogens 2012;8(6):e1002763.
2012: Melanie Kremer; Michael H Lehmann; Monir Majzoub; Yasemin Suezer; Theresa Frenz; Kay-Martin Hanschmann; Ulrich Kalinke; Asisa Volz; Gerd Sutter
Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.
PLoS pathogens 2012;8(3):e1002557.
2011: Stefan Schülke; Masako Toda; Stefan Vieths; Zoe Waibler; Andrea Wangorsch; Sonja Wolfheimer; Manja Burggraf; Ulrich Kalinke; Stephan Scheurer
A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy.
The Journal of allergy and clinical immunology 2011;128(6):1340-1348.e12.
2011: Meike S Gratz; Yasemin Suezer; Melanie Kremer; Asisa Volz; Monir Majzoub; Kay-Martin Hanschmann; Ulrich Kalinke; Astrid Schwantes; Gerd Sutter
N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.
Journal of virology 2011;85(7):3557-69.
2010: Georg Kochs; Stefanie Bauer; Carola Vogt; Theresa Frenz; Jürg Tschopp; Ulrich Kalinke; Zoe Waibler
Thogoto virus infection induces sustained type I interferon responses that depend on RIG-I-like helicase signaling of conventional dendritic cells.
Journal of virology 2010;84(23):12344-50.
2010: Theresa Frenz; Zoe Waibler; Janin Hofmann; Matthias Hamdorf; Markus Lantermann; Boris Reizis; Michaël G Tovey; Peter Aichele; Gerd Sutter; Ulrich Kalinke
Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion.
European journal of immunology 2010;40(10):2769-77.
2010: Marco Prinz; Ulrich Kalinke
New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNS.
Trends in molecular medicine 2010;16(8):379-86.
2010: Philipp A Lang; Mike Recher; Nadine Honke; Stefanie Scheu; Stephanie Borkens; Nicole Gailus; Caroline Krings; Andreas Meryk; Andreas Kulawik; Luisa Cervantes-Barragan; Nico van Rooijen; Ulrich Kalinke; Burkhard Ludewig; Hans Hengartner; Nicola Harris; Dieter Häussinger; Pamela S Ohashi; Rolf M Zinkernagel; Karl S Lang
Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice.
Hepatology (Baltimore, Md.) 2010;52(1):25-32.
2010: Linda Y Sender; Kathrin Gibbert; Yasemin Suezer; Heinfried Radeke; Ulrich Kalinke; Zoe Waibler
CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signals.
Molecular immunology 2010;47(6):1255-61.
2010: Anne Ilchmann; Sven Burgdorf; Stephan Scheurer; Zoe Waibler; Ryoji Nagai; Anne Wellner; Yasuhiko Yamamoto; Hiroshi Yamamoto; Thomas Henle; Christian Kurts; Ulrich Kalinke; Stefan Vieths; Masako Toda
Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II.
The Journal of allergy and clinical immunology 2010;125(1):175-83.e1-11.
2009: Andreas Pilz; Wolfgang Kratky; Silvia Stockinger; Olivia Simma; Ulrich Kalinke; Karen Lingnau; Alexander von Gabain; Dagmar Stoiber; Veronika Sexl; Thomas Kolbe; Thomas Rülicke; Mathias Müller; Thomas Decker
Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(4):2286-93.
2009: Patricia Bach; Jakob-A Tschäpe; Ferdinand Kopietz; Gundula Braun; Janina K Baade; Karl-Heinz Wiederhold; Matthias Staufenbiel; Marco Prinz; Thomas Deller; Ulrich Kalinke; Christian J Buchholz; Ulrike C Müller
Vaccination with Abeta-displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(12):7613-24.
2009: Cornelia Richter; Martina Herrero San Juan; Jutta Will; Ralf P Brandes; Ulrich Kalinke; Shizuo Akira; Josef M Pfeilschifter; Malin Hultqvist; Rikard Holmdahl; Heinfried Radeke
Ncf1 provides a reactive oxygen species-independent negative feedback regulation of TLR9-induced IL-12p70 in murine dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(7):4183-91.
2009: Silvia Stockinger; Renate Kastner; Elisabeth Kernbauer; Andreas Pilz; Sandra Westermayer; Benjamin Reutterer; Didier Soulat; Gabriele Stengl; Claus Vogl; Theresa Frenz; Zoe Waibler; Tadatsugu Taniguchi; Thomas Rülicke; Ulrich Kalinke; Mathias Müller; Thomas Decker
Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes.
PLoS pathogens 2009;5(3):e1000355.
2009: Claudia N Detje; Thomas Meyer; Hauke Schmidt; Dorothea Kreuz; John K Rose; Ingo Bechmann; Marco Prinz; Ulrich Kalinke
Local type I IFN receptor signaling protects against virus spread within the central nervous system.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(4):2297-304.
2009: Zoe Waibler; Martina Anzaghe; Theresa Frenz; Astrid Schwantes; Christopher Pöhlmann; Holger Ludwig; Marcos Palomo-Otero; Antonio Alcamí; Gerd Sutter; Ulrich Kalinke
Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.
Journal of virology 2009;83(4):1563-71.
2008: Werner Muller; Martina Anzaghe; Abdo Konur; Shizuo Akira; Werner Müller; Ulrich Kalinke
Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-alpha responses by pDC.
European journal of immunology 2008;38(11):3127-37.
2008: Zoe Waibler; Linda Y Sender; Christel Kamp; Jan Muller-Berghaus; Bernd Liedert; Christian K Schneider; Johannes Löwer; Ulrich Kalinke
Toward experimental assessment of receptor occupancy: TGN1412 revisited.
The Journal of allergy and clinical immunology 2008;122(5):890-2.
2008: Christian K Schneider; Ulrich Kalinke
Toward biosimilar monoclonal antibodies.
Nature biotechnology 2008;26(9):985-90.
2008: Burkhart Schraven; Ulrich Kalinke
CD28 superagonists: what makes the difference in humans?
Immunity 2008;28(5):591-5.
2008: Marie-Cécile Michallet; Etienne Meylan; Maria A Ermolaeva; Jessica Vazquez; Manuele Rebsamen; Joseph Curran; Hendrik Poeck; Michael Bscheider; Gunther Hartmann; Martin König; Ulrich Kalinke; Manolis Pasparakis; Jürg Tschopp
TRADD protein is an essential component of the RIG-like helicase antiviral pathway.
Immunity 2008;28(5):651-61.
2008: Marco Prinz; Hauke Schmidt; Alexander Mildner; Klaus-Peter Knobeloch; Uwe-Karsten Hanisch; Jenni Raasch; Doron Merkler; Claudia Detje; Ilona Gutcher; Jörg Mages; Roland Lang; Roland Martin; Ralf Gold; Burkhard Becher; Wolfgang Brück; Ulrich Kalinke
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
Immunity 2008;28(5):675-86.
2008: Zoe Waibler; Linda Y Sender; Camilla Merten; Roland Hartig; Stefanie Kliche; Matthias Gunzer; Peter Reichardt; Ulrich Kalinke; Burkhart Schraven
Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies.
PloS one 2008;3(3):e1708.
2007: Ozlem Demirel; Zoe Waibler; Ulrich Kalinke; Frank Grünebach; Silke Appel; Peter Brossart; Andrej Hasilik; Robert Tampé; Rupert Abele
Identification of a lysosomal peptide transport system induced during dendritic cell development.
The Journal of biological chemistry 2007;282(52):37836-43.
2007: Zoe Waibler; Martina Anzaghe; Holger Ludwig; Shizuo Akira; Siegfried Weiss; Gerd Sutter; Ulrich Kalinke
Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
Journal of virology 2007;81(22):12102-10.
2007: Christian K Schneider; Ulrich Kalinke
[After the TGN1412 incident. Principles for assessment of first-in-man trials with monoclonal antibodies by the Paul Ehrlich Institute].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2007;50(10):1213-20.
2007: Patricia Bach; Elisabeth Kamphuis; Bernhard Odermatt; Gerd Sutter; Christian J Buchholz; Ulrich Kalinke
Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(9):5839-47.
2007: Gjon Blakqori; Sophie Delhaye; Matthias Habjan; Carol D Blair; Irma Sánchez-Vargas; Ken E Olson; Ghassem Attarzadeh-Yazdi; Rennos Fragkoudis; Alain Kohl; Ulrich Kalinke; Siegfried Weiss; Thomas Michiels; Peter Staeheli; Friedemann Weber
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.
Journal of virology 2007;81(10):4991-9.
2007: Ulrike Schleicher; Jan Liese; Ilka Knippertz; Claudia Kurzmann; Andrea Hesse; Antje Heit; Jens A. A. Fischer; Siegfried Weiss; Ulrich Kalinke; Stefanie Kunz; Christian Bogdan
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
The Journal of experimental medicine 2007;204(4):893-906.
2007: Zoe Waibler; Ulrich Kalinke; Jutta Will; Martina Herrero San Juan; Josef M Pfeilschifter; Heinfried Radeke
TLR-ligand stimulated interleukin-23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells.
Molecular immunology 2007;44(7):1483-9.
2007: Anke Osterloh; Ulrich Kalinke; Siegfried Weiss; Bernhard Fleischer; Minka Breloer
Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide.
The Journal of biological chemistry 2007;282(7):4669-80.
2007: Iris Koerner; Georg Kochs; Ulrich Kalinke; Siegfried Weiss; Peter Staeheli
Protective role of beta interferon in host defense against influenza A virus.
Journal of virology 2007;81(4):2025-30.
2007: Zoe Waibler; Claudia N Detje; John C Bell; Ulrich Kalinke
Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells.
Immunobiology 2007;212(9-10):887-94.
2007: B Liedert; S Bassus; Christian K Schneider; Ulrich Kalinke; Johannes Löwer
Safety of phase I clinical trials with monoclonal antibodies in Germany--the regulatory requirements viewed in the aftermath of the TGN1412 disaster.
International journal of clinical pharmacology and therapeutics 2007;45(1):1-9.
2006: Elisabeth Kamphuis; Tobias Junt; Zoe Waibler; Reinhold Forster; Ulrich Kalinke
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia.
Blood 2006;108(10):3253-61.
2006: Caroline Staib; Yasemin Suezer; Sigrid Kisling; Ulrich Kalinke; Gerd Sutter
Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara.
The Journal of general virology 2006;87(Pt 10):2917-21.
2006: Thomas Hinz; Christian J Buchholz; Ton van der Stappen; Klaus Cichutek; Ulrich Kalinke
Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspective.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(5):472-6.
2006: Silke Schüle; Stefanie Steidl; Sylvia Panitz; Cheick Coulibaly; Ulrich Kalinke; Klaus Cichutek; Matthias Schweizer
Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.
Virology 2006;351(1):237-47.
2006: Christian K Schneider; Ulrich Kalinke; Johannes Löwer
TGN1412--a regulator's perspective.
Nature biotechnology 2006;24(5):493-6.
2006: Holger Ludwig; Yasemin Suezer; Zoe Waibler; Ulrich Kalinke; Barbara S Schnierle; Gerd Sutter
Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara.
The Journal of general virology 2006;87(Pt 5):1145-55.
2006: Agnes Le Bon; Vanessa Durand; Elisabeth Kamphuis; Clare Thompson; Silvia Bulfone-Paus; Cornelia Rossmann; Ulrich Kalinke; David F Tough
Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(8):4682-9.
2006: Peter Aichele; Heike Unsoeld; Marie Koschella; Oliver Schweier; Ulrich Kalinke; Smiljka Vucikuja
CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(8):4525-9.
2006: Nicole Gerlach; Simone Schimmer; Siegfried Weiss; Ulrich Kalinke; Ulf Dittmer
Effects of type I interferons on Friend retrovirus infection.
Journal of virology 2006;80(7):3438-44.
2006: Christian J Buchholz; Patricia Bach; Daphne Nikles; Ulrich Kalinke
Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies.
Expert opinion on biological therapy 2006;6(3):293-300.
2006: Agnes Le Bon; Clare Thompson; Elisabeth Kamphuis; Vanessa Durand; Cornelia Rossmann; Ulrich Kalinke; David F Tough
Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(4):2074-8.
2006: Ulrich Kalinke; Patricia Bach; Martin König; Christian J Buchholz
Vaccination against prion diseases.
Discovery medicine 2006;6(31):29-34.
2005: Birgit Strobl; Ivan Bubic; Ute Bruns; Ralf Steinborn; Robert Lajko; Thomas Kolbe; Marina Karaghiosoff; Ulrich Kalinke; Stipan Jonjic; Mathias Müller
Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(6):4000-8.
2005: Diana-Ines Dominguez; Jos Tournoy; Dieter Hartmann; Tobias Huth; Kim Cryns; Siska Deforce; Lutgarde Serneels; Ira Espuny Camacho; Els Marjaux; Katleen Craessaerts; Anton J M Roebroek; Michael Schwake; Rudi D'Hooge; Patricia Bach; Ulrich Kalinke; Dieder Moechars; Christian Alzheimer; Karina Reiss; Paul Saftig; Bart De Strooper
Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice.
The Journal of biological chemistry 2005;280(35):30797-806.
2005: Daphne Nikles; Patricia Bach; Klaus Boller; Christoph A Merten; Fabio Montrasio; Frank L Heppner; Adriano Aguzzi; Klaus Cichutek; Ulrich Kalinke; Christian J Buchholz
Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.
Journal of virology 2005;79(7):4033-42.
2004: Marc Meier-Noorden; Sven Flindt; Ulrich Kalinke; Thomas Hinz
A CpG-rich bidirectional promoter induces the T-cell death-associated gene 51 and downregulates an inversely oriented transcript during early T-cell activation.
Gene 2004;338(2):197-207.
2003: Lars Hangartner; Beatrice M Senn; Birgit Ledermann; Ulrich Kalinke; Peter Seiler; Etienne Bucher; Raphaël M Zellweger; Katja Fink; Bernhard Odermatt; Kurt Bürki; Rolf M Zinkernagel; Hans Hengartner
Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(22):12883-8.
2003: Beatrice M Senn; Constantino López-Macías; Ulrich Kalinke; Alain Lamarre; armando isibasi; Rolf M Zinkernagel; Hans Hengartner
Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections.
European journal of immunology 2003;33(4):950-61.
2002: Stefanie Scheu; Judith Alferink; Tobias Pötzel; Winfried Barchet; Ulrich Kalinke; Klaus Pfeffer
Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.
The Journal of experimental medicine 2002;195(12):1613-24.
2002: Winfried Barchet; Marina Cella; Bernhard Odermatt; Carine Asselin-Paturel; Marco COLONna; Ulrich Kalinke
Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo.
The Journal of experimental medicine 2002;195(4):507-16.
2001: Frank L Heppner; I Arrighi; Ulrich Kalinke; A Aguzzi
Immunity against prions?
Trends in molecular medicine 2001;7(11):477-9.
2001: Frank L Heppner; Christine Huber-Musahl; I Arrighi; Michael A Klein; Thomas Rülicke; Bruno Oesch; Rolf M Zinkernagel; Ulrich Kalinke; Adriano Aguzzi
Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.
Science (New York, N.Y.) 2001;294(5540):178-82.
2001: Michael A Klein; PS Kaeser; Petra Schwarz; H Weyd; I Xenarios; Rolf M Zinkernagel; M C Carroll; Sjef Verbeek; M Botto; M J Walport; H Molina; Ulrich Kalinke; H Acha-Orbea; Adriano Aguzzi
Complement facilitates early prion pathogenesis.
Nature medicine 2001;7(4):488-92.
2001: Rolf M Zinkernagel; Alain Lamarre; Adrian Ciurea; Lukas Hunziker; Adrian F Ochsenbein; Kathy D McCoy; Thomas Fehr; Martin F Bachmann; Ulrich Kalinke; Hans Hengartner
Neutralizing antiviral antibody responses.
Advances in immunology 2001;79():1-53.
2000: Ulrich Kalinke; Annette Oxenius; C Lopez-Macias; Rolf M Zinkernagel; H Hengartner
Virus neutralization by germ-line vs. hypermutated antibodies.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(18):10126-31.
2000: Peter Seiler; Beatrice M Senn; Paul Klenerman; Ulrich Kalinke; Hans Hengartner; Rolf M Zinkernagel
Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.
Journal of virology 2000;74(13):5896-901.
2000: Urs Karrer; Constantino López-Macías; Annette Oxenius; Bernhard Odermatt; M F Bachmann; Ulrich Kalinke; Horst Bluethmann; Hans Hengartner; Rolf M Zinkernagel
Antiviral B cell memory in the absence of mature follicular dendritic cell networks and classical germinal centers in TNFR1-/- mice.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(2):768-78.
1999: Constantino López-Macías; Ulrich Kalinke; Marilia I Cascalho; Matthias Wabl; Hans Hengartner; Rolf M Zinkernagel; Alain Lamarre
Secondary rearrangements and hypermutation generate sufficient B cell diversity to mount protective antiviral immunoglobulin responses.
The Journal of experimental medicine 1999;189(11):1791-8.
1999: Peter Seiler; Beatrice M Senn; MA Bründler; Rolf M Zinkernagel; Hans Hengartner; Ulrich Kalinke
In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4536-41.
1998: G A Funk; A D Barbour; Hans Hengartner; Ulrich Kalinke
Mathematical model of a virus-neutralizing immunglobulin response.
Journal of theoretical biology 1998;195(1):41-52.
1998: Peter Seiler; Ulrich Kalinke; Thomas Rülicke; Etienne Bucher; C Böse; Rolf M Zinkernagel; Hans Hengartner
Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice.
Journal of virology 1998;72(3):2253-8.
1997: Michael A Klein; Rico Frigg; Eckhard Flechsig; Alex J Raeber; Ulrich Kalinke; Horst Bluethmann; F Bootz; M Suter; Rolf M Zinkernagel; Adriano Aguzzi
A crucial role for B cells in neuroinvasive scrapie.
Nature 1997;390(6661):687-90.
1997: Martin F Bachmann; Ulrich Kalinke; Alana Althage; G Freer; C Burkhart; H Roost; M Aguet; Hans Hengartner; Rolf M Zinkernagel
The role of antibody concentration and avidity in antiviral protection.
Science (New York, N.Y.) 1997;276(5321):2024-7.
1997: Thomas Fehr; Martin F Bachmann; Etienne Bucher; Ulrich Kalinke; F E Di Padova; A B Lang; Hans Hengartner; Rolf M Zinkernagel
Role of repetitive antigen patterns for induction of antibodies against antibodies.
The Journal of experimental medicine 1997;185(10):1785-92.
1996: Ulrich Kalinke; Etienne Bucher; B Ernst; A Oxenius; H P Roost; Stephan Geley; Reinhard Kofler; Rolf M Zinkernagel; Hans Hengartner
The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus.
Immunity 1996;5(6):639-52.
1996: Ulrich Kalinke; A Krebber; C Krebber; Etienne Bucher; Andreas Plückthun; Rolf M Zinkernagel; Hans Hengartner
Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection.
European journal of immunology 1996;26(12):2801-6.
1996: M Battegay; P Fiedler; Ulrich Kalinke; F Brombacher; Rolf M Zinkernagel; H H Peter; Gabriele Köhler; H Eibel
Non-tolerant B cells cause autoimmunity in anti-CD8 IgG2a-transgenic mice.
European journal of immunology 1996;26(1):250-8.
1995: H P Roost; Martin F Bachmann; A Haag; Ulrich Kalinke; V Pliska; Hans Hengartner; Rolf M Zinkernagel
Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(5):1257-61.
1994: D U Kalinke; Ulrich Kalinke; Jan-Olof Winberg; A König; J Lauharanta; A M Christiano; J Uitto; Leena Bruckner-Tuderman
Collagen VII in severe recessive dystrophic epidermolysis bullosa: expression of mRNA but lack of intact protein product in skin and cutaneous cells in vitro.
The Journal of investigative dermatology 1994;102(2):260-2.